AC Immune Announces Upcoming Industry Symposium on Parkinson's Disease and Presentation at AD/PD™ 2026 [Yahoo! Finance]
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week [Yahoo! Finance]
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD [Seeking Alpha]